CCN2 and systemic sclerosis: This upregulation of CCN2 in SSc fibroblasts provided support for CCN2 as a pro-fibrotic mediator and to prove this concept, we examined whether knocking down CCN2 expression using siRNA could attenuate the fibrotic phenotype in vitro.